| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peritoneal Neoplasms | 11 | 2015 | 821 | 1.010 |
Why?
|
| Chemotherapy, Cancer, Regional Perfusion | 7 | 2015 | 169 | 0.660 |
Why?
|
| Appendiceal Neoplasms | 5 | 2015 | 234 | 0.630 |
Why?
|
| Hyperthermia, Induced | 9 | 2015 | 510 | 0.620 |
Why?
|
| Mitomycin | 5 | 2013 | 208 | 0.420 |
Why?
|
| Fas Ligand Protein | 2 | 2013 | 150 | 0.400 |
Why?
|
| Nanotubes, Carbon | 1 | 2009 | 29 | 0.350 |
Why?
|
| Phototherapy | 1 | 2009 | 75 | 0.340 |
Why?
|
| Mesothelioma | 3 | 2010 | 544 | 0.330 |
Why?
|
| Organoplatinum Compounds | 3 | 2013 | 702 | 0.330 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 2483 | 0.310 |
Why?
|
| Pleural Neoplasms | 2 | 2009 | 470 | 0.280 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 2291 | 0.280 |
Why?
|
| Biopsy, Fine-Needle | 7 | 2013 | 690 | 0.260 |
Why?
|
| Drug Delivery Systems | 1 | 2009 | 669 | 0.250 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 3 | 1991 | 132 | 0.250 |
Why?
|
| Combined Modality Therapy | 11 | 2015 | 8865 | 0.250 |
Why?
|
| Cytodiagnosis | 3 | 2015 | 220 | 0.250 |
Why?
|
| Cisplatin | 5 | 2013 | 2432 | 0.240 |
Why?
|
| Genes, Wilms Tumor | 3 | 2010 | 64 | 0.220 |
Why?
|
| Osteosarcoma | 4 | 2013 | 929 | 0.220 |
Why?
|
| Lymphoma, AIDS-Related | 1 | 2002 | 70 | 0.210 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2006 | 436 | 0.210 |
Why?
|
| Reactive Oxygen Species | 1 | 2007 | 987 | 0.210 |
Why?
|
| Parotid Neoplasms | 1 | 2002 | 148 | 0.200 |
Why?
|
| Cytoreduction Surgical Procedures | 2 | 2015 | 475 | 0.190 |
Why?
|
| Colorectal Neoplasms | 3 | 2014 | 3578 | 0.190 |
Why?
|
| Apoptosis | 6 | 2013 | 7591 | 0.170 |
Why?
|
| Adenosine Triphosphate | 3 | 1991 | 571 | 0.160 |
Why?
|
| Biopsy, Needle | 4 | 2015 | 1363 | 0.160 |
Why?
|
| Sentinel Lymph Node Biopsy | 4 | 2011 | 1415 | 0.160 |
Why?
|
| Bone Neoplasms | 5 | 2013 | 2576 | 0.150 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 7 | 2015 | 15862 | 0.150 |
Why?
|
| Genetic Techniques | 1 | 1998 | 130 | 0.150 |
Why?
|
| fas Receptor | 3 | 2013 | 185 | 0.150 |
Why?
|
| Cytological Techniques | 3 | 2011 | 74 | 0.140 |
Why?
|
| Antineoplastic Agents | 8 | 2013 | 14289 | 0.140 |
Why?
|
| Endosonography | 2 | 2009 | 536 | 0.140 |
Why?
|
| Biological Products | 1 | 2019 | 274 | 0.140 |
Why?
|
| Survival Rate | 11 | 2019 | 12221 | 0.140 |
Why?
|
| Peritoneal Stomata | 1 | 2015 | 1 | 0.140 |
Why?
|
| Tissue Embedding | 1 | 2015 | 28 | 0.130 |
Why?
|
| Colonic Neoplasms | 2 | 2014 | 1390 | 0.130 |
Why?
|
| Sampling Studies | 1 | 2015 | 170 | 0.130 |
Why?
|
| Neuroblastoma | 2 | 2011 | 686 | 0.130 |
Why?
|
| Sensitivity and Specificity | 5 | 2015 | 4971 | 0.130 |
Why?
|
| Histiocytoma, Malignant Fibrous | 1 | 2015 | 51 | 0.130 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2013 | 38 | 0.110 |
Why?
|
| Tumor Burden | 1 | 2019 | 1987 | 0.110 |
Why?
|
| Melanoma | 4 | 2019 | 5317 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 6 | 2013 | 5395 | 0.110 |
Why?
|
| Diaphragm | 1 | 2014 | 181 | 0.110 |
Why?
|
| Carcinoma | 3 | 2013 | 2578 | 0.110 |
Why?
|
| Kidney | 3 | 2010 | 2146 | 0.110 |
Why?
|
| Administration, Inhalation | 1 | 2013 | 285 | 0.110 |
Why?
|
| Lung Neoplasms | 6 | 2013 | 11538 | 0.110 |
Why?
|
| Peritoneal Cavity | 1 | 2012 | 56 | 0.110 |
Why?
|
| Point Mutation | 2 | 2009 | 769 | 0.100 |
Why?
|
| Humans | 47 | 2019 | 261506 | 0.100 |
Why?
|
| Male | 29 | 2019 | 123000 | 0.100 |
Why?
|
| Carcinoma, Signet Ring Cell | 1 | 2013 | 170 | 0.100 |
Why?
|
| Alleles | 1 | 1998 | 2437 | 0.100 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2011 | 42 | 0.100 |
Why?
|
| Synovitis, Pigmented Villonodular | 2 | 2003 | 15 | 0.100 |
Why?
|
| Multiple Myeloma | 1 | 2002 | 2138 | 0.100 |
Why?
|
| Immunohistochemistry | 4 | 2015 | 7548 | 0.100 |
Why?
|
| Cytoplasm | 1 | 2013 | 652 | 0.100 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2010 | 107 | 0.090 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2013 | 406 | 0.090 |
Why?
|
| Female | 27 | 2019 | 141928 | 0.090 |
Why?
|
| Frasier Syndrome | 1 | 2009 | 8 | 0.090 |
Why?
|
| Gonadoblastoma | 1 | 2009 | 9 | 0.090 |
Why?
|
| Immunoenzyme Techniques | 4 | 2015 | 1165 | 0.090 |
Why?
|
| Prognosis | 10 | 2019 | 21713 | 0.090 |
Why?
|
| Neoplasm Staging | 10 | 2015 | 13658 | 0.090 |
Why?
|
| Dysgerminoma | 1 | 2009 | 42 | 0.090 |
Why?
|
| Hypothalamic Neoplasms | 1 | 2009 | 21 | 0.090 |
Why?
|
| Interleukin-2 | 1 | 2013 | 842 | 0.090 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2019 | 1249 | 0.090 |
Why?
|
| Middle Aged | 23 | 2019 | 86204 | 0.090 |
Why?
|
| Genes, BRCA2 | 1 | 2012 | 309 | 0.090 |
Why?
|
| RNA Splice Sites | 1 | 2009 | 111 | 0.090 |
Why?
|
| Mice, Nude | 4 | 2013 | 4307 | 0.090 |
Why?
|
| Genes, BRCA1 | 1 | 2012 | 387 | 0.090 |
Why?
|
| BK Virus | 1 | 2010 | 123 | 0.080 |
Why?
|
| Neoplasms | 1 | 2015 | 15193 | 0.080 |
Why?
|
| Cystitis | 1 | 2010 | 107 | 0.080 |
Why?
|
| Needles | 1 | 2009 | 107 | 0.080 |
Why?
|
| Polyomavirus Infections | 1 | 2010 | 139 | 0.080 |
Why?
|
| Follow-Up Studies | 8 | 2019 | 14889 | 0.080 |
Why?
|
| Retrospective Studies | 13 | 2019 | 37905 | 0.080 |
Why?
|
| Kidney Medulla | 1 | 1988 | 43 | 0.080 |
Why?
|
| Tumor Virus Infections | 1 | 2010 | 224 | 0.080 |
Why?
|
| Lasers | 1 | 2009 | 198 | 0.080 |
Why?
|
| Cobalt | 1 | 1988 | 55 | 0.080 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 460 | 0.080 |
Why?
|
| Tretinoin | 1 | 2011 | 623 | 0.080 |
Why?
|
| Hot Temperature | 1 | 2009 | 281 | 0.080 |
Why?
|
| Kidney Neoplasms | 3 | 2010 | 3022 | 0.080 |
Why?
|
| Organometallic Compounds | 1 | 1989 | 191 | 0.080 |
Why?
|
| Killer Cells, Natural | 1 | 2013 | 904 | 0.080 |
Why?
|
| Databases, Factual | 1 | 2015 | 2218 | 0.080 |
Why?
|
| Receptors, Notch | 1 | 2011 | 383 | 0.080 |
Why?
|
| Wilms Tumor | 1 | 2010 | 292 | 0.080 |
Why?
|
| Aged | 18 | 2019 | 70117 | 0.080 |
Why?
|
| Aged, 80 and over | 11 | 2015 | 29902 | 0.080 |
Why?
|
| Benzamides | 1 | 2013 | 1832 | 0.080 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2009 | 221 | 0.080 |
Why?
|
| Cell Nucleus | 1 | 2013 | 1620 | 0.080 |
Why?
|
| Carcinoma, Lobular | 1 | 2011 | 611 | 0.080 |
Why?
|
| Hepatectomy | 1 | 2014 | 1011 | 0.080 |
Why?
|
| Astrocytoma | 1 | 2009 | 321 | 0.070 |
Why?
|
| Caspase 8 | 1 | 2007 | 145 | 0.070 |
Why?
|
| Adult | 18 | 2015 | 77950 | 0.070 |
Why?
|
| ras Proteins | 1 | 2011 | 770 | 0.070 |
Why?
|
| Germ-Line Mutation | 1 | 2012 | 1046 | 0.070 |
Why?
|
| Drug Synergism | 2 | 2007 | 1313 | 0.070 |
Why?
|
| Repressor Proteins | 2 | 2011 | 1664 | 0.070 |
Why?
|
| Ultrasonography, Interventional | 1 | 2009 | 429 | 0.070 |
Why?
|
| Pyridines | 1 | 2013 | 1244 | 0.070 |
Why?
|
| Pancreas | 1 | 2009 | 718 | 0.070 |
Why?
|
| Neoplasm Grading | 3 | 2015 | 1742 | 0.070 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2010 | 519 | 0.070 |
Why?
|
| Sickle Cell Trait | 1 | 2005 | 31 | 0.060 |
Why?
|
| Carcinoma, Ductal | 1 | 2006 | 145 | 0.060 |
Why?
|
| Sheep | 3 | 1991 | 258 | 0.060 |
Why?
|
| Liver Neoplasms | 2 | 2014 | 4557 | 0.060 |
Why?
|
| Skin Neoplasms | 3 | 2007 | 4654 | 0.060 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2006 | 222 | 0.060 |
Why?
|
| Prospective Studies | 6 | 2015 | 12873 | 0.060 |
Why?
|
| Lymph Nodes | 4 | 2009 | 2967 | 0.060 |
Why?
|
| Lymphatic Metastasis | 5 | 2014 | 4844 | 0.060 |
Why?
|
| Lymphoma | 1 | 2013 | 1467 | 0.060 |
Why?
|
| Coccidioides | 1 | 2003 | 7 | 0.060 |
Why?
|
| Mice | 6 | 2013 | 34495 | 0.060 |
Why?
|
| Antigens, Surface | 1 | 2004 | 295 | 0.060 |
Why?
|
| Coccidioidomycosis | 1 | 2003 | 32 | 0.060 |
Why?
|
| Animals | 9 | 2013 | 59536 | 0.060 |
Why?
|
| ADP-ribosyl Cyclase | 1 | 2002 | 33 | 0.060 |
Why?
|
| Carcinoma, Medullary | 1 | 2005 | 248 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2006 | 1323 | 0.060 |
Why?
|
| Depsipeptides | 1 | 2003 | 78 | 0.050 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2002 | 73 | 0.050 |
Why?
|
| Mitochondria | 2 | 2007 | 1282 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 1991 | 624 | 0.050 |
Why?
|
| Homosexuality, Male | 1 | 2002 | 71 | 0.050 |
Why?
|
| Lymphatic Diseases | 1 | 2003 | 128 | 0.050 |
Why?
|
| DNA Primers | 2 | 2010 | 1399 | 0.050 |
Why?
|
| Peptides, Cyclic | 1 | 2003 | 139 | 0.050 |
Why?
|
| ErbB Receptors | 1 | 2011 | 2295 | 0.050 |
Why?
|
| ADP-ribosyl Cyclase 1 | 1 | 2002 | 141 | 0.050 |
Why?
|
| Osteolysis | 1 | 2002 | 80 | 0.050 |
Why?
|
| Flavonoids | 1 | 2003 | 188 | 0.050 |
Why?
|
| Young Adult | 7 | 2015 | 21445 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2011 | 2488 | 0.050 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2003 | 311 | 0.050 |
Why?
|
| Cyclins | 1 | 2003 | 456 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2011 | 11965 | 0.050 |
Why?
|
| Sarcoma, Ewing | 1 | 2005 | 406 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2007 | 1493 | 0.050 |
Why?
|
| Lymphoma, Follicular | 1 | 2006 | 587 | 0.050 |
Why?
|
| Cell Survival | 1 | 2007 | 3045 | 0.050 |
Why?
|
| Skull | 1 | 2002 | 231 | 0.050 |
Why?
|
| Osteomyelitis | 1 | 2003 | 236 | 0.050 |
Why?
|
| Obesity | 1 | 2013 | 2884 | 0.050 |
Why?
|
| Viral Load | 1 | 2002 | 493 | 0.050 |
Why?
|
| Carboplatin | 2 | 2013 | 823 | 0.050 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2005 | 852 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2002 | 829 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2011 | 4078 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2011 | 5319 | 0.050 |
Why?
|
| Risk Factors | 2 | 2015 | 17523 | 0.040 |
Why?
|
| Anti-HIV Agents | 1 | 2002 | 350 | 0.040 |
Why?
|
| Cell Line, Tumor | 3 | 2011 | 14551 | 0.040 |
Why?
|
| Lymphoma, B-Cell | 1 | 2006 | 895 | 0.040 |
Why?
|
| Thalidomide | 1 | 2002 | 569 | 0.040 |
Why?
|
| Herpesvirus 1, Human | 1 | 2019 | 113 | 0.040 |
Why?
|
| Hodgkin Disease | 1 | 2007 | 1429 | 0.040 |
Why?
|
| Molecular Conformation | 2 | 1989 | 171 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2007 | 3821 | 0.040 |
Why?
|
| Suicide | 1 | 2001 | 180 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2007 | 2359 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2005 | 1533 | 0.040 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2004 | 713 | 0.040 |
Why?
|
| Base Sequence | 2 | 2010 | 4917 | 0.040 |
Why?
|
| Dementia, Multi-Infarct | 1 | 1997 | 2 | 0.040 |
Why?
|
| Radiography | 1 | 2002 | 1904 | 0.040 |
Why?
|
| DNA Ligases | 1 | 1998 | 63 | 0.040 |
Why?
|
| Cerebral Arterial Diseases | 1 | 1997 | 6 | 0.040 |
Why?
|
| Treatment Outcome | 5 | 2013 | 32848 | 0.040 |
Why?
|
| Paclitaxel | 1 | 2005 | 1996 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 1073 | 0.040 |
Why?
|
| Piperidines | 1 | 2003 | 1035 | 0.040 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 1 | 1997 | 46 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 1 | 1998 | 418 | 0.040 |
Why?
|
| Dexamethasone | 1 | 2002 | 1450 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2002 | 1385 | 0.040 |
Why?
|
| Metalloendopeptidases | 1 | 1998 | 170 | 0.040 |
Why?
|
| Diagnosis, Differential | 4 | 2013 | 4744 | 0.040 |
Why?
|
| Child | 7 | 2015 | 29154 | 0.040 |
Why?
|
| Chromosome Aberrations | 1 | 2004 | 1960 | 0.040 |
Why?
|
| Interleukin-1 | 1 | 1998 | 461 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 10035 | 0.030 |
Why?
|
| Ovarian Neoplasms | 1 | 2012 | 4638 | 0.030 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2003 | 882 | 0.030 |
Why?
|
| Brain | 2 | 2001 | 4113 | 0.030 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2006 | 1664 | 0.030 |
Why?
|
| Receptor, ErbB-2 | 1 | 2005 | 2518 | 0.030 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2007 | 2390 | 0.030 |
Why?
|
| Breast Neoplasms | 2 | 2011 | 15694 | 0.030 |
Why?
|
| Disease Progression | 1 | 2006 | 6682 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 1 | 2014 | 197 | 0.030 |
Why?
|
| Binding Sites | 2 | 1989 | 2171 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2013 | 3033 | 0.030 |
Why?
|
| Thiosulfates | 1 | 2013 | 8 | 0.030 |
Why?
|
| Registries | 1 | 2002 | 2170 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2007 | 8873 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 5159 | 0.030 |
Why?
|
| Adolescent | 5 | 2014 | 31252 | 0.030 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2013 | 56 | 0.030 |
Why?
|
| Survival Analysis | 3 | 2013 | 9180 | 0.030 |
Why?
|
| Peritoneum | 1 | 2013 | 150 | 0.030 |
Why?
|
| Preoperative Care | 2 | 2012 | 1529 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 1998 | 1038 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2001 | 855 | 0.030 |
Why?
|
| Perfusion | 1 | 2014 | 293 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2013 | 223 | 0.030 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2014 | 181 | 0.030 |
Why?
|
| Biomarkers, Tumor | 3 | 2015 | 10331 | 0.030 |
Why?
|
| Sarcoma | 1 | 2003 | 1725 | 0.030 |
Why?
|
| Peritoneal Lavage | 1 | 2012 | 21 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 1998 | 1450 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1998 | 1538 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2005 | 4367 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2010 | 6550 | 0.030 |
Why?
|
| Abdominal Neoplasms | 1 | 2013 | 231 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 1998 | 3203 | 0.030 |
Why?
|
| Transcription Factor HES-1 | 1 | 2011 | 49 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2011 | 246 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 1062 | 0.020 |
Why?
|
| Mutation | 1 | 2011 | 15179 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2012 | 330 | 0.020 |
Why?
|
| Codon | 1 | 2011 | 241 | 0.020 |
Why?
|
| Immunophenotyping | 2 | 2006 | 1681 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2011 | 154 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 650 | 0.020 |
Why?
|
| Gonadal Dysgenesis, 46,XY | 1 | 2009 | 26 | 0.020 |
Why?
|
| Body Fluids | 1 | 2011 | 125 | 0.020 |
Why?
|
| Mediastinoscopy | 1 | 2009 | 31 | 0.020 |
Why?
|
| Hemianopsia | 1 | 2009 | 42 | 0.020 |
Why?
|
| Molecular Structure | 1 | 1991 | 515 | 0.020 |
Why?
|
| DNA | 1 | 1998 | 2693 | 0.020 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2002 | 2326 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2010 | 634 | 0.020 |
Why?
|
| Infusions, Parenteral | 1 | 2009 | 191 | 0.020 |
Why?
|
| Speech Disorders | 1 | 2009 | 91 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2013 | 7226 | 0.020 |
Why?
|
| Esophageal Neoplasms | 1 | 2003 | 3168 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 1217 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2006 | 5767 | 0.020 |
Why?
|
| Proteinuria | 1 | 2009 | 155 | 0.020 |
Why?
|
| Genetic Engineering | 1 | 2010 | 288 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 2314 | 0.020 |
Why?
|
| Mosaicism | 1 | 2010 | 272 | 0.020 |
Why?
|
| Pleura | 1 | 2009 | 127 | 0.020 |
Why?
|
| Hydrogen | 1 | 1988 | 58 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 1082 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2010 | 905 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 1988 | 300 | 0.020 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2009 | 209 | 0.020 |
Why?
|
| Manganese | 1 | 1988 | 80 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2011 | 589 | 0.020 |
Why?
|
| Regression Analysis | 2 | 2002 | 1546 | 0.020 |
Why?
|
| Doxorubicin | 2 | 2005 | 3005 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2013 | 2232 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2011 | 622 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2010 | 1519 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2013 | 6150 | 0.020 |
Why?
|
| Exons | 1 | 2011 | 1328 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 3536 | 0.020 |
Why?
|
| Acid Phosphatase | 1 | 2006 | 59 | 0.020 |
Why?
|
| Frozen Sections | 1 | 2007 | 105 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 3639 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2010 | 848 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2010 | 1869 | 0.020 |
Why?
|
| Protons | 1 | 1989 | 473 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 4298 | 0.020 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2009 | 551 | 0.020 |
Why?
|
| Equipment Design | 1 | 2009 | 1204 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2006 | 182 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2011 | 1143 | 0.020 |
Why?
|
| Pregnancy | 2 | 2010 | 7573 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2010 | 769 | 0.020 |
Why?
|
| Cell Membrane | 1 | 1989 | 850 | 0.020 |
Why?
|
| Intraoperative Care | 1 | 2007 | 259 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2006 | 218 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2010 | 712 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2013 | 3890 | 0.020 |
Why?
|
| Kinetics | 1 | 1988 | 2049 | 0.020 |
Why?
|
| Paraffin Embedding | 1 | 2005 | 226 | 0.020 |
Why?
|
| Ifosfamide | 1 | 2005 | 344 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2011 | 2283 | 0.020 |
Why?
|
| Thymidine | 1 | 2004 | 155 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2007 | 671 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 5112 | 0.020 |
Why?
|
| Hematuria | 1 | 2005 | 85 | 0.020 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2011 | 1216 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2010 | 2450 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2011 | 1863 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2011 | 1331 | 0.020 |
Why?
|
| Pneumonectomy | 1 | 2009 | 831 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 3101 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2010 | 2843 | 0.010 |
Why?
|
| Skin Pigmentation | 1 | 2003 | 47 | 0.010 |
Why?
|
| Phenotype | 2 | 2009 | 6295 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2005 | 553 | 0.010 |
Why?
|
| Knee | 1 | 2003 | 33 | 0.010 |
Why?
|
| Groin | 1 | 2003 | 74 | 0.010 |
Why?
|
| Inguinal Canal | 1 | 2003 | 60 | 0.010 |
Why?
|
| Herpesvirus 4, Human | 1 | 2007 | 966 | 0.010 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2007 | 489 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 3154 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2004 | 272 | 0.010 |
Why?
|
| Phosphorylation | 1 | 1991 | 4804 | 0.010 |
Why?
|
| Prostate-Specific Antigen | 1 | 2006 | 993 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2004 | 402 | 0.010 |
Why?
|
| Trastuzumab | 1 | 2005 | 696 | 0.010 |
Why?
|
| Methotrexate | 1 | 2005 | 999 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 2003 | 429 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2004 | 576 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2011 | 7551 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2003 | 528 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2002 | 6100 | 0.010 |
Why?
|
| Amyloid Neuropathies | 1 | 2001 | 1 | 0.010 |
Why?
|
| Neurofibrillary Tangles | 1 | 2001 | 24 | 0.010 |
Why?
|
| Lewy Body Disease | 1 | 2001 | 20 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2011 | 2669 | 0.010 |
Why?
|
| Transplantation Conditioning | 1 | 2010 | 2238 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 6009 | 0.010 |
Why?
|
| Autopsy | 1 | 2001 | 173 | 0.010 |
Why?
|
| Vincristine | 1 | 2004 | 1511 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 2489 | 0.010 |
Why?
|
| Ki-67 Antigen | 1 | 2002 | 666 | 0.010 |
Why?
|
| Lung | 1 | 2011 | 3151 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 2508 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2005 | 2074 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2005 | 1085 | 0.010 |
Why?
|
| Organ Size | 1 | 2001 | 690 | 0.010 |
Why?
|
| Lymph Node Excision | 1 | 2007 | 1959 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 2004 | 1245 | 0.010 |
Why?
|
| Hematologic Neoplasms | 1 | 2010 | 1870 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 5539 | 0.010 |
Why?
|
| Crystallins | 1 | 1997 | 29 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 7222 | 0.010 |
Why?
|
| Gene Expression | 1 | 2006 | 3570 | 0.010 |
Why?
|
| Ubiquitins | 1 | 1997 | 86 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2004 | 3001 | 0.010 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 1997 | 161 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 1997 | 331 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1998 | 1037 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 1879 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2007 | 10001 | 0.010 |
Why?
|
| Hippocampus | 1 | 2001 | 915 | 0.010 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2005 | 3251 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 3719 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 2009 | 5061 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2009 | 7789 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2005 | 16273 | 0.010 |
Why?
|
| Genetic Variation | 1 | 1997 | 2086 | 0.010 |
Why?
|